86 related articles for article (PubMed ID: 22177699)
1. NRIP enhances HPV gene expression via interaction with either GR or E2.
Chang SW; Lu PY; Guo JH; Tsai TC; Tsao YP; Chen SL
Virology; 2012 Feb; 423(1):38-48. PubMed ID: 22177699
[TBL] [Abstract][Full Text] [Related]
2. NRIP, a novel calmodulin binding protein, activates calcineurin to dephosphorylate human papillomavirus E2 protein.
Chang SW; Tsao YP; Lin CY; Chen SL
J Virol; 2011 Jul; 85(13):6750-63. PubMed ID: 21543494
[TBL] [Abstract][Full Text] [Related]
3. Viral interaction: a possible contributing factor in head and neck cancer progression.
Underbrink MP; Hoskins SL; Pou AM; Albrecht T
Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus E2 protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells.
Wu MH; Chan JY; Liu PY; Liu ST; Huang SM
Int J Biochem Cell Biol; 2007; 39(2):413-25. PubMed ID: 17092759
[TBL] [Abstract][Full Text] [Related]
5. E2 and the co-activator p300 can cooperate in activation of the human papillomavirus type 16 early promoter.
Krüppel U; Müller-Schiffmann A; Baldus SE; Smola-Hess S; Steger G
Virology; 2008 Jul; 377(1):151-9. PubMed ID: 18495195
[TBL] [Abstract][Full Text] [Related]
6. [Research progress in roles of high-risk human papillomavirus E2 protein].
Wu EQ; Tang YY
Bing Du Xue Bao; 2014 Mar; 30(2):201-7. PubMed ID: 24923176
[TBL] [Abstract][Full Text] [Related]
7. Failure to interact with Brd4 alters the ability of HPV16 E2 to regulate host genome expression and cellular movement.
Gauson EJ; Wang X; Dornan ES; Herzyk P; Bristol M; Morgan IM
Virus Res; 2016 Jan; 211():1-8. PubMed ID: 26365679
[TBL] [Abstract][Full Text] [Related]
8. CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2.
Bhattacharjee B; Sengupta S
Virology; 2006 Oct; 354(2):280-5. PubMed ID: 16905170
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of hormone response of human papillomavirus type 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements.
Khare S; Kumar KU; Tang SC; Pater MM; Pater A
J Med Virol; 1996 Nov; 50(3):254-62. PubMed ID: 8923291
[TBL] [Abstract][Full Text] [Related]
10. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin.
Donaldson MM; Boner W; Morgan IM
J Virol; 2007 Apr; 81(8):4338-42. PubMed ID: 17287259
[TBL] [Abstract][Full Text] [Related]
11. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
12. The human papillomavirus E7-E2 interaction mechanism in vitro reveals a finely tuned system for modulating available E7 and E2 proteins.
Smal C; Wetzler DE; Dantur KI; Chemes LB; Garcia-Alai MM; Dellarole M; Alonso LG; Gaston K; de Prat-Gay G
Biochemistry; 2009 Dec; 48(50):11939-49. PubMed ID: 19899811
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human papillomavirus type 16 early gene expression in trophoblastic and cervical cells.
Weyn C; Vanderwinden JM; Rasschaert J; Englert Y; Fontaine V
Virology; 2011 Mar; 412(1):146-55. PubMed ID: 21276600
[TBL] [Abstract][Full Text] [Related]
14. Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.
Fujii T; Austin D; Guo D; Srimatkandada S; Wang T; Kubushiro K; Masumoto N; Tsukazaki K; Nozawa S; Deisseroth AB
Clin Cancer Res; 2003 Nov; 9(14):5423-8. PubMed ID: 14614029
[TBL] [Abstract][Full Text] [Related]
15. The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis.
Wang W; Wang S; Song X; Sima N; Xu X; Luo A; Chen G; Deng D; Xu Q; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Jun; 105(3):571-7. PubMed ID: 17433827
[TBL] [Abstract][Full Text] [Related]
16. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
17. Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix.
Lindel K; de Villiers EM; Burri P; Studer U; Altermatt HJ; Greiner RH; Gruber G
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):760-5. PubMed ID: 16682151
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes.
Fontan CT; Das D; Bristol ML; James CD; Wang X; Lohner H; Atfi A; Morgan IM
mSphere; 2020 Dec; 5(6):. PubMed ID: 33298572
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus 16 E2 stability and transcriptional activation is enhanced by E1 via a direct protein-protein interaction.
King LE; Dornan ES; Donaldson MM; Morgan IM
Virology; 2011 May; 414(1):26-33. PubMed ID: 21458836
[TBL] [Abstract][Full Text] [Related]
20. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
